In the setting of gastritis, symptomatic therapy may be considered and is occasionally useful in clarifying the diagnosis of gastritis. H2-blocker therapy can be considered in the setting of gastroesophageal reflux after consultation with the primary care provider or gastroenterologist. Inpatient management includes frequent evaluation of volume status, replacement of fluid deficit and ongoing losses, and attempts at establishing and demonstrating oral intake sufficient to maintain volume status given the patient's severity of diarrhea and vomiting. IV hydration should be guided by calculations of fluid replacement based upon the clinical estimate of volume depletion. In some patients, special solutions need to be ordered to correct electrolyte and acid-base abnormalities.
Parents often focus on the frequency of vomiting and diarrhea instead of on patient volume status.
Parents should be given clear instructions on amounts and types of fluids to be given during the course of the illness. Clinical presentations that include these diagnoses as considerations should be thoroughly investigated and the clinician's evaluation clearly documented. Antidiarrheal medications have adverse effects and generally are not necessary. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Medicine is a constantly changing science and not all therapies are clearly established.